Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1340014

	registered interest
	date	24/06/2021
	answering body	Foreign, Commonwealth and Development Office
	answering dept id	208
	answering dept short name	Foreign, Commonwealth and Development Office
	answering dept sort name	Foreign, Commonwealth and Development Office
	hansard heading	South Africa: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps the Government is taking to encourage (a) Pfizer and (b) Moderna to share their mRNA technology with the South African mRNA vaccine technology transfer hub to facilitate regional vaccine manufacturing.
	tabling member constituency	Harrow West
	tabling member printed	Gareth Thomas
	uin	21806
	answer	answer is ministerial correction date of answer 30/06/2021 answer text <p>Alongside our G7 partners, the UK is committed to working internationally on efforts to support our ambitious shared goal of vaccinating the world by the end of 2022. This includes efforts to increase vaccine supply by working with suppliers to boost manufacturing, and develop more sustainable approaches to support COVAX as well as wider future pandemic preparedness.</p><p>Building vaccine manufacturing capacity is a long term, capital intensive, and high risk endeavour that will require sustained partnerships for supporting viable business models. We are working with the COVAX Supply Chains and Manufacturing Task Force, multilateral, and industry partners to expand quality and affordable vaccine supplies, smooth supply chains, support better information sharing and match making to increase trusted partnerships for manufacturing. The UK has funded McKinsey to scope opportunities for increasing vaccine manufacturing in Africa, and supported the African Union's Africa Manufacturing summit in April this year. We were also the largest funder of Coalition for Epidemic Preparedness Innovations (CEPI) in 2020, which is leading work internationally to increase vaccine manufacturing capacity.</p> answering member constituency Aldridge-Brownhills answering member printed Wendy Morton question first answered 30/06/2021 11:28:22 answering member 4358 label Biography information for Wendy Morton
	tabling member	177 label Biography information for Gareth Thomas

1340013

	registered interest
	date	24/06/2021
	answering body	Foreign, Commonwealth and Development Office
	answering dept id	208
	answering dept short name	Foreign, Commonwealth and Development Office
	answering dept sort name	Foreign, Commonwealth and Development Office
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what the UK’s contribution will be to the G7 target of vaccinating the world by 2022; and if he will make a statement.
	tabling member constituency	Harrow West
	tabling member printed	Gareth Thomas
	uin	21805
	answer	answer is ministerial correction date of answer 02/07/2021 answer text <p>The UK has played a leading role in supporting global access to safe and effective COVID-19 vaccines. The UK is among the largest donors to COVAX, which aims to provide vaccine doses for up to 30% of the population in low and middle-income countries by early 2022. The UK's investment in the research and development of the Oxford/AstraZeneca vaccine has also been a key contribution to the global vaccination effort. So far, over 500 million doses of the vaccine have been distributed worldwide at non-profit prices, with two-thirds going to lower and middle- income countries.</p><p>The UK is proud that our G7 Presidency secured agreement from leaders to commit to sharing at least 870 million doses over the next year, including a commitment from the UK to share 100 million doses. In addition, we are working closely with G7 and international partners to mobilise international financing, increase vaccine supply, and support in-country delivery, including community mobilisation, and building vaccine confidence.</p> answering member constituency Aldridge-Brownhills answering member printed Wendy Morton question first answered 02/07/2021 10:47:11 answering member 4358 label Biography information for Wendy Morton
	tabling member	177 label Biography information for Gareth Thomas

1340011

	registered interest
	date	24/06/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Coronavirus: International Cooperation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, with reference to the UK’s statement from the last TRIPS Council meeting on June 9th, what steps he is taking to (a) incentivise UK industries to participate in the Covid-19 Technology Access Pool and (b) encourage further engagement by other World Trade Organisation members with the C-TAP scheme.
	tabling member constituency	Harrow West
	tabling member printed	Gareth Thomas
	uin	21803
	answer	answer is ministerial correction date of answer 01/07/2021 answer text <p>The UK has, and will continue to, engage extensively with all interested parties. We are in ongoing, constructive discussions with the World Health Organisation (WHO) as it refines both governance structures and operating model for the Covid Technology Access Pool (C-TAP). The UK has recently worked with the WHO on developing C-TAP, including with key partners such as the United Nations Development Programme and the Medicines Patent Pool, to share our approach to model licenses for IP. We are keen to see, and have facilitated, the WHO working with industry to incentivise participation in the scheme and we have encouraged WTO members to engage with C-TAP.</p> answering member constituency Derby North answering member printed Amanda Solloway question first answered 01/07/2021 14:08:13 answering member 4372 label Biography information for Amanda Solloway
	tabling member	177 label Biography information for Gareth Thomas

1340012

	registered interest
	date	24/06/2021
	answering body	Department for International Trade
	answering dept id	202
	answering dept short name	International Trade
	answering dept sort name	International Trade
	hansard heading	Coronavirus: International Cooperation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for International Trade, whether she will allow low- and middle-income countries to waive intellectual property rights on covid-19 (a) vaccines, (b) therapies and (c) diagnostics in line with Indian and South African government’s proposal at the World Trade Organisation to allow the necessary scale-up in production required.
	tabling member constituency	Harrow West
	tabling member printed	Gareth Thomas
	uin	21804
	answer	answer is ministerial correction date of answer 29/06/2021 answer text <p>I refer the Hon. Gentleman for Harrow West to the answer I gave to the Hon. Gentleman for Birkenhead on 17<sup>th</sup> May 2021 (UIN: 448).</p> answering member constituency North East Hampshire answering member printed Mr Ranil Jayawardena question first answered 29/06/2021 10:28:01 answering member 4498 label Biography information for Mr Ranil Jayawardena
	tabling member	177 label Biography information for Gareth Thomas